Clinical Trials Directory

Trials / Sponsors / Tibotec BVBA

Tibotec BVBA

Industry · 18 registered clinical trials.

StatusTrialPhaseStarted
TerminatedTMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safet
Hepatitis C Virus
Phase 12011-06-01
CompletedTMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Int
Healthy Volunteer
Phase 12011-02-01
CompletedVX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Hepatitis C
Phase 12010-12-01
CompletedA Study of TMC207 in Patients With Moderately Impaired Hepatic Function
Moderate Hepatic Impairment
Phase 12010-01-01
CompletedVX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (
Hepatitis C
Phase 12009-10-01
CompletedVX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
Hepatitis C
Phase 12009-09-01
CompletedA Study to Determine the Relative Oral Bioavailability of Single Dose Administration of TMC207, Under Fed and
Healthy
Phase 12009-08-01
CompletedA Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State
Healthy Participants
Phase 12009-07-01
CompletedVX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevi
Hepatitis C, Kidney Diseases
Phase 12009-06-01
CompletedTMC207-TiDP13-C117: Interaction Study in Human Immunodeficiency Virus-type 1 (HIV-1) Infected Patients With Ne
HIV Infections
Phase 12009-06-01
CompletedVX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fuma
Hepatitis C, HCV, HIV
Phase 12009-02-01
CompletedTMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer
Tuberculosis, HIV
Phase 12009-02-01
CompletedA Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previo
Hepatitis C, Chronic
Phase 32008-10-01
CompletedVX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprev
Hepatitis C, Telaprevir, HIV
Phase 12008-06-01
CompletedAn Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus I
Hepatitis C
Phase 22008-01-01
CompletedA Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepa
Hepatitis C, Chronic
Phase 22007-12-01
CompletedAn Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated In
Chronic Hepatitis C
Phase 22007-10-01
CompletedTMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-
Tuberculosis
Phase 22005-05-01